Yunnan Botanee Bio-Technology Group Co.LTD Share Price

Equities

300957

CNE100004G74

Personal Products

End-of-day quote Shenzhen S.E. 23:00:00 18/04/2024 BST 5-day change 1st Jan Change
55.35 CNY -1.95% Intraday chart for Yunnan Botanee Bio-Technology Group Co.LTD -2.89% -18.81%

Financials

Sales 2023 * 6.08B 839M 67.76B Sales 2024 * 7.62B 1.05B 84.97B Capitalization 23.45B 3.24B 261B
Net income 2023 * 1.21B 167M 13.49B Net income 2024 * 1.5B 206M 16.67B EV / Sales 2023 * 3.37 x
Net cash position 2023 * 2.96B 409M 32.99B Net cash position 2024 * 3.72B 514M 41.52B EV / Sales 2024 * 2.59 x
P/E ratio 2023 *
19.2 x
P/E ratio 2024 *
15.5 x
Employees 3,053
Yield 2023 *
1.56%
Yield 2024 *
1.86%
Free-Float 27.75%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023. CI
Certain A Shares of Yunnan Botanee Bio-Technology Group Co.LTD are subject to a Lock-Up Agreement Ending on 25-MAR-2024. CI
Weimai Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Yunnan Botanee Bio-Technology Group Co.LTD CI
Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd. CI
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023. CI
In China's slowing beauty market, big brand discounts won't cut it RE
Shanghai Weimu Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd., SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd. CI
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 87 Yuan From 105 Yuan, Keeps at Hold MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback. CI
Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD CI
Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares. CI
Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan. CI
Yunnan Botanee’s H1 Profit Jumps 14% as Revenue Grows 15.5% MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2023 CI
More news
1 day-1.95%
1 week-2.89%
Current month-7.70%
1 month-15.42%
3 months-15.84%
6 months-37.59%
Current year-18.81%
More quotes
1 week
54.62
Extreme 54.62
57.78
1 month
54.62
Extreme 54.62
63.33
Current year
51.50
Extreme 51.5
72.00
1 year
51.50
Extreme 51.5
117.75
3 years
51.50
Extreme 51.5
289.35
5 years
51.50
Extreme 51.5
289.35
10 years
51.50
Extreme 51.5
289.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 31/05/14
Director of Finance/CFO 42 30/11/16
Director/Board Member 45 30/06/12
Members of the board TitleAgeSince
Director/Board Member 56 30/09/13
Chief Executive Officer 61 31/05/14
Director/Board Member 42 31/12/12
More insiders
Date Price Change Volume
19/04/24 55.35 -1.95% 1,938,341
18/04/24 56.45 -0.05% 3,642,463
17/04/24 56.48 +2.65% 2,493,274
16/04/24 55.02 -1.57% 2,261,187
15/04/24 55.9 -1.93% 2,501,552

End-of-day quote Shenzhen S.E., April 18, 2024

More quotes
Yunnan Botanee Bio-Technology Group Co LTD is a Chinese company mainly engaged in the production of cosmetics. The Company adopts a sales model based on offline channel sales and online channel sales as the leading factor. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
55.35 CNY
Average target price
90.33 CNY
Spread / Average Target
+63.20%
Consensus
  1. Stock Market
  2. Equities
  3. 300957 Stock